HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

Triethylamine → (2S)-ethyl 2-tert-butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-((2-(trimethylsilyl)ethoxy)carbonylamino)pyrazolo[1,5-a]pyrimidin-6-yl)acetate

HRID 1468748
Notes
Print preview

Reaction equation

HRID 1468748 reaction equation
[C:1]([O:5][C@@H:6]([C:12]1[C:13]([CH3:36])=[N:14][C:15]2[N:16]([N:30]=[C:31](C(O)=O)[CH:32]=2)[C:17]=1[C:18]1[C:19]([CH3:29])=[C:20]2[C:25](=[C:26]([F:28])[CH:27]=1)[O:24][CH2:23][CH2:22][CH2:21]2)[C:7]([O:9][CH2:10][CH3:11])=[O:8])([CH3:4])([CH3:3])[CH3:2].C1(P(N=[N+]=[N-])(C2C=CC=CC=2)=[O:44])C=CC=CC=1.[CH3:54][Si:55]([CH3:60])([CH3:59])[CH2:56][CH2:57][OH:58].C([N:63]([CH2:66]C)CC)C>C1(C)C=CC=CC=1>[C:1]([O:5][C@@H:6]([C:12]1[C:13]([CH3:36])=[N:14][C:15]2[N:16]([N:30]=[C:31]([NH:63][C:66]([O:58][CH2:57][CH2:56][Si:55]([CH3:60])([CH3:59])[CH3:54])=[O:44])[CH:32]=2)[C:17]=1[C:18]1[C:19]([CH3:29])=[C:20]2[C:25](=[C:26]([F:28])[CH:27]=1)[O:24][CH2:23][CH2:22][CH2:21]2)[C:7]([O:9][CH2:10][CH3:11])=[O:8])([CH3:3])([CH3:4])[CH3:2]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

6

Reactant 4

HCID 8471TriethylamineHCID 180132-(Trimethylsilyl)ethanolHCID 199401P,P-Diphenylphosphinic azideHCID 712583786-((S)-1-(tert-butoxy)-2-ethoxy-2-oxoethyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-a]pyrimidine-2-carboxylic acid

Product 1

HCID 86695369
(2S)-ethyl 2-tert-butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-((2-(trimethylsilyl)ethoxy)carbonylamino)pyrazolo[1,5-a]pyrimidin-6-yl)acetate
Yield 70.2%

Reagents, catalysts & solvents 1

HCID 1140TolueneSolvent

Procedure

A mixture of 6-((S)-1-(tert-butoxy)-2-ethoxy-2-oxoethyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-a]pyrimidine-2-carboxylic acid (3.40 g, 5.79 mmol), diphenylphosphoryl azide (1.50 mL, 6.94 mmol), 2-(trimethylsilyl)ethanol (1.66 mL, 11.6 mmol), triethylamine (0.968 mL, 6.94 mmol) in toluene (100 mL) was refluxed for 16 h. It was then concentrated in vacuo. The residue was purified by biotage eluting with 20% EtOAc/hexane to isolate 2.5 g (70%) of (2S)-ethyl 2-tert-butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-((2-(trimethylsilyl)ethoxy)carbonylamino)pyrazolo[1,5-a]pyrimidin-6-yl)acetate as off-white solid. 1H NMR (500 MHz, CDCl3) δ 7.25 (s, 1H), 6.89 (s, 1H), 6.87 (d, J=6.9 Hz, 1H), 4.90 (s, 1H), 4.34 (m, 2H), 4.30 (m, 2H), 4.13 (d, J=7.1 Hz, 2H), 2.84-2.63 (m, 5H), 2.18 (m, 2H), 1.84 (s, 3H), 1.20 (t, J=7.1 Hz, 3H), 1.17 (s, 9H), 1.05 (m, 2H), 0.07 (s, 9H). LCMS (M+H)=615.4.

Workup

  1. temperaturewas refluxed for 16 h
  2. concentrationIt was then concentrated in vacuo
  3. customThe residue was purified by biotage
  4. washeluting with 20% EtOAc/hexane

Sources & evidence

ORD record
ord-6a6bbdbe4ccf487290101d27b1b67bce
Source dataset
uspto-grants-2015_04
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US09006235B2

Reaction notes

Loading…

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes